» Articles » PMID: 2933595

Cerebral Metabolism in Hyper- and Hypocarbia: 31P and 1H Nuclear Magnetic Resonance Studies

Overview
Journal Neurology
Specialty Neurology
Date 1985 Dec 1
PMID 2933595
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Paralyzed rabbits ventilated with an oxygen, nitrous oxide, and carbon dioxide mixture were subjected to hyper- and hypocarbic stress. An Oxford Instrument TMR 32-200 spectrometer was used to record phosphorus-31 and nonwater proton nuclear magnetic resonance spectra of the in vivo brain. These spectra provide measurements of cerebral pHi, phosphocreatine, orthophosphate, ATP, and lactate. The brain exhibited twice as much acute pH-regulating ability as the arterial blood. During hypercarbia, orthophosphate rose while phosphocreatine declined in a reciprocal manner, and ATP remained constant. During hypocarbia, lactate rose gradually over a period of 1 hour, while orthophosphate, phosphocreatine, and ATP remained constant and calculated values of adenosine mono- and diphosphate rose.

Citing Articles

Neurovascular coupling is optimized to compensate for the increase in proton production from nonoxidative glycolysis and glycogenolysis during brain activation and maintain homeostasis of pH, pCO, and pO.

DiNuzzo M, Dienel G, Behar K, Petroff O, Benveniste H, Hyder F J Neurochem. 2023; 168(5):632-662.

PMID: 37150946 PMC: 10628336. DOI: 10.1111/jnc.15839.


Maintenance of Energy Homeostasis during Calorically Restricted Ketogenic Diet and Fasting-MR-Spectroscopic Insights from the ERGO2 Trial.

Wenger K, Wagner M, Harter P, Franz K, Bojunga J, Fokas E Cancers (Basel). 2020; 12(12).

PMID: 33261052 PMC: 7760797. DOI: 10.3390/cancers12123549.


A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Rae C Neurochem Res. 2013; 39(1):1-36.

PMID: 24258018 DOI: 10.1007/s11064-013-1199-5.


Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease.

Tkac I, Henry P, Zacharoff L, Wedel M, Gong W, Deelchand D J Cereb Blood Flow Metab. 2012; 32(11):1977-88.

PMID: 22805874 PMC: 3493992. DOI: 10.1038/jcbfm.2012.104.


Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study.

Hattingen E, Jurcoane A, Bahr O, Rieger J, Magerkurth J, Anti S Neuro Oncol. 2011; 13(12):1349-63.

PMID: 21890539 PMC: 3223092. DOI: 10.1093/neuonc/nor132.